معرفی
James Trauer is an Associate Professor (Research) in Biostatistics, Data Analytics/Modelling, and Health Economics at Monash University, leading the Epidemiological Modelling Unit within the School of Public Health and Preventive Medicine. He specializes in infectious disease dynamics, with a focus on tuberculosis (TB) and pandemic response strategies for diseases like COVID-19. His work integrates deterministic/stochastic modelling, Bayesian inference, and health economics, collaborating globally with WHO regions and institutions such as the Burnet Institute and Murdoch Children's Research Institute.
Education and Research Interests: Trauer’s research spans TB epidemiology, pandemic preparedness, and health systems modeling. He has led projects in multiple countries, including Malaysia, Vietnam, and Papua New Guinea, and contributed to WHO’s pandemic modeling frameworks. His clinical work includes respiratory and sleep medicine at the Alfred Hospital and the Victorian TB Program.
Notable Achievements: Recognized with the 2021 Victorian Tall Poppy Award and a WHO Innovation Challenge Award, Trauer’s team developed modular platforms for epidemiological modeling in pandemic control. His work addresses UN SDGs related to good health (SDG 3) and sustainable cities (SDG 11). Key research areas include TB elimination strategies, vaccine impact modeling, and behavioral sleep disorders.
Grants and Collaborations: Active in global health initiatives, Trauer leads projects funded by the Global Fund and NHMRC, focusing on TB control and zoonotic pandemic preparedness. His recent grants include capacity-building programs in Southeast Asia and studies on pediatric immune responses to SARS-CoV-2. He collaborates with multidisciplinary teams across clinical, computational, and policy domains.
- Key Projects:
- Modelling TB transmission in high/low burden settings
- Covid-19 counterfactual scenario analysis for NT Department of Health
- PROPHECY: Immune response profiling in high-risk populations
Labs/Teams: Head of the Epidemiological Modelling Unit, collaborating with global partners like WHO and the TB Modelling and Analysis Consortium.
